Why is Penumbra, Inc. ?
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 201.5 MM
- ROCE(HY) Highest at 12.03%
- DEBT-EQUITY RATIO (HY) Lowest at -15.77 %
How much should you hold?
- Overall Portfolio exposure to Penumbra, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Penumbra, Inc. for you?
Medium Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 276.66 MM
Highest at 8.28 times
Fallen by 0.23% (YoY
Highest at USD 1,160.48 MM
Lowest at -27.11 %
Lowest at 13,504.1
Lowest at USD 42.81 MM
Lowest at 11.42 %
Lowest at USD 41.69 MM
Lowest at USD 32.58 MM
Lowest at USD 0.82
Here's what is working for Penumbra, Inc.
Operating Cash Flows (USD MM)
Debtors Turnover Ratio
Cash and Cash Equivalents
Debt-Equity Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for Penumbra, Inc.
Operating Profit to Interest
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)






